Semler Scientific (NASDAQ:SMLR - Get Free Report) will likely be posting its quarterly earnings results before the market opens on Tuesday, February 18th. Analysts expect Semler Scientific to post earnings of $0.20 per share for the quarter. Parties that are interested in registering for the company's conference call can do so using this link.
Semler Scientific Price Performance
SMLR traded up $0.22 during trading on Monday, hitting $49.67. The company had a trading volume of 226,526 shares, compared to its average volume of 424,548. Semler Scientific has a 1-year low of $20.88 and a 1-year high of $81.56. The company has a market cap of $460.44 million, a PE ratio of 24.23 and a beta of 1.17. The business has a 50-day moving average of $57.88 and a 200-day moving average of $42.15.
Wall Street Analyst Weigh In
Separately, Lake Street Capital increased their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a research report on Friday, January 24th.
View Our Latest Report on SMLR
Semler Scientific Company Profile
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Featured Stories

Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.